Logo Glaukos Corp.

Glaukos Corp. (GKOS) stock: analyst price target and their real reliability

Live quote · data updated Oct 14, 2026
Glaukos Corp. · Health Care · ref. ETF XLV · 91 calls · price $165.5
🏆JPI 2026 portfoliosSee tracking →
What the company does: Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.

📈 Glaukos Corp. (GKOS) stock price

$165.5+94.0% over range
Oct 14, 25low $74.67 · high $189.55Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
91% recommend buying · 11 analysts
📊 JPI status : Glaukos Corp. is no longer in our current JPI rankings, but appeared in the past (2022, 2018) — its upside may be behind it. See the stocks picked in 2022 →

🎯 GKOS price target & analyst consensus — price $166

The price target · all analysts combined (11 targets)
Highest target · 1 firm of 11$215+29.9%
Median target · of 11 targets$195+17.8%
Lowest target · 1 firm of 11$140-15.4%
Current price$165.5
Where these 11 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 1091% $172 ↔ $215
Below 19% $140
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Jefferies — 61% of its targets hit on this sector (137 calls tested). It aims for $210 (+27 %), call made on September 23, 2026, maturing on September 23, 2027 (21 d ago).

The 3 reliable analysts $195+18 %
The 8 other firms $193+16 %
How to read it: the 3 reliable firms are not filtered by optimism — 3 aim above the price, 0 below, hence their $195 median. “The 8 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 11 ratings (last 6 months)
Strong Buy00%
Buy1091%
Hold19%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Glaukos Corp.? The JPI assistant answers using our backtest data.

🔎 Detailed analyses

✅ Historical analyst reliability on GKOS

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm ↕ % right i ↕ Gain vs sector i ↕ Calls i ↕
Roth Capital 100% +76.1% 3
Cantor Fitzgerald ↗ 100% +21.2% 3
Stephens & Co. ↗ 86% +89.0% 7
BMO Capital ↗ 80% +72.8% 5
Needham ↗ 77% +45.2% 13
Piper Sandler ↗ 75% +56.9% 8
JP Morgan ↗ 56% +23.7% 9
Citigroup ↗ 56% -0.0% 9
Truist Securities ↗ 54% +29.2% 13
UBS ↗ 50% +35.5% 2
See the other 6 firms
Wells Fargo ↗ 23% -21.4% 13
BTIG ↗ 45% +19.5% 11
Stifel ↗ 45% +20.4% 11
Morgan Stanley ↗ 50% -14.2% 2
William Blair ↗ 50% +1.0% 2
Mizuho ↗ 50% +5.6% 2

📊 What $1,000 invested in Glaukos Corp. would be worth › open the full page

In short — $1,000 invested in Glaukos Corp. 10 years ago would be worth $6,175 today, i.e. +20%/yr on average. Best year: 2018 (+119%), worst: 2021 (-41%). Price performance, excluding dividends.

If I'd invested $1,000 in Glaukos Corp.

InvestmentWorth todayGain
1 years ago$1,017+2%
3 years ago$3,490+249%
5 years ago$2,026+103%
→ See Glaukos Corp.'s full return history + gain calculator

Return by year (Glaukos Corp.)

YearReturn$1,000 invested at year start
2026 (YTD)+35%$1,350 (+35%)
2025-25%$1,017 (+2%)
2024+89%$1,918 (+92%)
→ See Glaukos Corp.'s full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Glaukos Corp.

Loading news…

📋 All analyst calls on GKOS

BTIG ↗
Oct 12, 26
▲ Buy · 🎯$205
Price at call : $168.02 — upside +22%
Today : $165.5 — upside +24%
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : Oct 12, 27
Jefferies ↗
Sep 22, 26
▲ Buy · 🎯$210
Price at call : $153.49 — upside +37%
Today : $165.5 — upside +27%
🎯 on GKOS : no call matured yet · 📊 on Health : 49.6% · +9.4% (137 calls)
in progress (365j)
matures : Sep 22, 27
BTIG ↗
Aug 20, 26
▲ Buy · 🎯$202
Price at call : $184.89 — upside +9%
Today : $165.5 — upside +22%
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : Aug 20, 27
UBS ↗
Jul 30, 26
■ Neutral neutral · not a buy · 🎯$172
Price at call : $166.72 — gap to target +3%
Today : $165.5 — gap to target +4%
🎯 on GKOS : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Jul 30, 27
▲ Buy · 🎯$195
Price at call : $166.72 — upside +17%
Today : $165.5 — upside +18%
🎯 on GKOS : no call matured yet · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Jul 30, 27
Citigroup ↗
Jul 30, 26
▲ Buy · 🎯$188
Price at call : $166.72 — upside +13%
Today : $165.5 — upside +14%
🎯 on GKOS : 100% (1 call matured) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Jul 30, 27
Piper Sandler ↗
Jul 30, 26
▲ Overweight · 🎯$195
Price at call : $166.72 — upside +17%
Today : $165.5 — upside +18%
🎯 on GKOS : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Jul 30, 27
Jefferies ↗
Jul 30, 26
▲ Buy · 🎯$190
Price at call : $166.72 — upside +14%
Today : $165.5 — upside +15%
🎯 on GKOS : no call matured yet · 📊 on Health : 49.6% · +9.4% (137 calls)
in progress (365j)
matures : Jul 30, 27
See the other 83 calls, newest to oldest
Stifel ↗
Jul 30, 26
▲ Buy · 🎯$190
Price at call : $166.72 — upside +14%
Today : $165.5 — upside +15%
🎯 on GKOS : no call matured yet · 📊 on Health : 44.3% · +6.0% (97 calls)
in progress (365j)
matures : Jul 30, 27
▲ Buy · 🎯$215
Price at call : $166.72 — upside +29%
Today : $165.5 — upside +30%
🎯 on GKOS : 50% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Jul 30, 27
Wells Fargo ↗
Jul 30, 26
▲ Overweight · 🎯$178
Price at call : $166.72 — upside +7%
Today : $165.5 — upside +8%
🎯 on GKOS : 17% (12 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : Jul 30, 27
Needham ↗
Jul 30, 26
▲ Buy · 🎯$201
Price at call : $168.52 — upside +19%
Today : $165.5 — upside +21%
🎯 on GKOS : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Jul 30, 27
BTIG ↗
Jul 30, 26
▲ Buy · 🎯$193
Price at call : $168.52 — upside +15%
Today : $165.5 — upside +17%
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : Jul 30, 27
Stifel ↗
Jul 17, 26
▲ Buy · 🎯$175
Price at call : $156.83 — upside +12%
Today : $165.5 — upside +6%
🎯 on GKOS : no call matured yet · 📊 on Health : 44.3% · +6.0% (97 calls)
in progress (365j)
matures : Jul 17, 27
▲ Buy · 🎯$180
Price at call : $156.83 — upside +15%
Today : $165.5 — upside +9%
🎯 on GKOS : 50% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Jul 16, 27
Citigroup ↗
Jul 8, 26
▲ Buy · 🎯$175
Price at call : $155.07 — upside +13%
Today : $165.5 — upside +6%
🎯 on GKOS : 100% (1 call matured) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Jul 8, 27
▲ Buy · 🎯$168
Price at call : $148.7 — upside +13%
Today : $165.5 — upside +2%
🎯 on GKOS : no call matured yet · 📊 on Health : 57.4% · +25.1% (329 calls)
in progress (365j)
matures : Jul 6, 27
Piper Sandler ↗
Jul 1, 26
▲ Overweight · 🎯$165
Price at call : $137.57 — upside +20%
Today : $165.5 — upside -0%
🎯 on GKOS : no call matured yet · 📊 on Health : 45.4% · +6.7% (251 calls)
in progress (365j)
matures : Jul 1, 27
Needham ↗
Jun 17, 26
▲ Buy · 🎯$150
Price at call : $127.41 — upside +18%
Today : $165.5 — upside -9%
🎯 on GKOS : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Jun 17, 27
Citigroup ↗
Jun 11, 26
▲ Buy · 🎯$162
Price at call : $126.81 — upside +28%
Today : $165.5 — upside -2%
🎯 on GKOS : 100% (1 call matured) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Jun 11, 27
BTIG ↗
Jun 10, 26
▲ Buy · 🎯$162
Price at call : $122.49 — upside +32%
Today : $165.5 — upside -2%
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : Jun 10, 27
BTIG ↗
May 21, 26
▲ Buy · 🎯$162
Price at call : $139.03 — upside +17%
Today : $165.5 — upside -2%
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : May 21, 27
BTIG ↗
May 20, 26
▲ Buy · 🎯$162
Price at call : $139.03 — upside +17%
Today : $165.5 — upside -2%
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : May 20, 27
JP Morgan ↗
May 1, 26
▲ Overweight · 🎯$140
Price at call : $140.22 — upside -0%
Today : $165.5 — upside -15%
🎯 on GKOS : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : May 1, 27
Citigroup ↗
Apr 30, 26
▲ Buy · 🎯$140
Price at call : $140.22 — upside -0%
Today : $165.5 — upside -15%
🎯 on GKOS : 100% (1 call matured) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Apr 30, 27
Wells Fargo ↗
Apr 30, 26
▲ Overweight · 🎯$138
Price at call : $143.67 — upside -4%
Today : $165.5 — upside -17%
🎯 on GKOS : 17% (12 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : Apr 30, 27
Needham ↗
Apr 30, 26
▲ Buy · 🎯$136
Price at call : $143.67 — upside -5%
Today : $165.5 — upside -18%
🎯 on GKOS : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Apr 30, 27
BTIG ↗
Apr 30, 26
▲ Buy · 🎯$141
Price at call : $143.67 — upside -2%
Today : $165.5 — upside -15%
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : Apr 30, 27
Wells Fargo ↗
Feb 18, 26
▲ Overweight · 🎯$135
Price at call : $121 — upside +12%
Today : $165.5 — upside -18%
🎯 on GKOS : 17% (12 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : Feb 18, 27
Needham ↗
Feb 18, 26
▲ Buy · 🎯$127
Price at call : $121 — upside +5%
Today : $165.5 — upside -23%
🎯 on GKOS : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Feb 18, 27
BTIG ↗
Feb 18, 26
▲ Buy · 🎯$131
Price at call : $121 — upside +8%
Today : $165.5 — upside -21%
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : Feb 18, 27
BTIG ↗
Jan 28, 26
▲ Buy · 🎯$131
Price at call : $119.07 — upside +10%
Today : $165.5 — upside -21%
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : Jan 28, 27
Stifel ↗
Jan 22, 26
▲ Buy · 🎯$160
Price at call : $125.9 — upside +27%
Today : $165.5 — upside -3%
🎯 on GKOS : no call matured yet · 📊 on Health : 44.3% · +6.0% (97 calls)
in progress (365j)
matures : Jan 22, 27
Needham ↗
Jan 14, 26
▲ Buy · 🎯$125
Price at call : $104.43 — upside +20%
Today : $165.5 — upside -24%
🎯 on GKOS : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Jan 14, 27
▲ Overweight · 🎯$145
Price at call : $110.72 — upside +31%
Today : $165.5 — upside -12%
🎯 on GKOS : 86% (7 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
in progress (365j)
matures : Jan 2, 27
BTIG ↗
Jan 2, 26
▲ Buy · 🎯$116
Price at call : $110.72 — upside +5%
Today : $165.5 — upside -30%
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : Jan 2, 27
UBS ↗
Dec 23, 25
▲ Buy · 🎯$145
Price at call : $116.64 — upside +24%
Today : $165.5 — upside -12%
🎯 on GKOS : no call matured yet · 📊 on Health : 48.7% · +2.2% (76 calls)
in progress (365j)
matures : Dec 23, 26
▲ Buy · 🎯$145
Price at call : $113.21 — upside +28%
Today : $165.5 — upside -12%
🎯 on GKOS : 50% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
in progress (365j)
matures : Dec 18, 26
Citigroup ↗
Dec 11, 25
▲ Buy · 🎯$125
Price at call : $108.88 — upside +15%
Today : $165.5 — upside -24%
🎯 on GKOS : 100% (1 call matured) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Dec 11, 26
Needham ↗
Dec 9, 25
▲ Buy · 🎯$125
Price at call : $108.72 — upside +15%
Today : $165.5 — upside -24%
🎯 on GKOS : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Dec 9, 26
JP Morgan ↗
Oct 30, 25
▲ Overweight · 🎯$120
Price at call : $88.07 — upside +36%
Today : $165.5 — upside -27%
🎯 on GKOS : no call matured yet · 📊 on Health : 49% · +6.7% (149 calls)
in progress (365j)
matures : Oct 30, 26
Citigroup ↗
Oct 30, 25
▲ Buy · 🎯$113
Price at call : $88.07 — upside +28%
Today : $165.5 — upside -32%
🎯 on GKOS : 100% (1 call matured) · 📊 on Health : 44.9% · -4.4% (107 calls)
in progress (365j)
matures : Oct 30, 26
Wells Fargo ↗
Oct 30, 25
▲ Overweight · 🎯$122
Price at call : $88.07 — upside +39%
Today : $165.5 — upside -26%
🎯 on GKOS : 17% (12 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : Oct 30, 26
Needham ↗
Oct 30, 25
▲ Buy · 🎯$117
Price at call : $87.8 — upside +33%
Today : $165.5 — upside -29%
🎯 on GKOS : no call matured yet · 📊 on Health : 39.2% · -2.7% (400 calls)
in progress (365j)
matures : Oct 30, 26
BTIG ↗
Oct 30, 25
▲ Buy · 🎯$116
Price at call : $87.8 — upside +32%
Today : $165.5 — upside -30%
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : Oct 30, 26
Wells Fargo ↗
Oct 27, 25
▲ Overweight · 🎯$120
Price at call : $75.68 — upside +59%
Today : $165.5 — upside -27%
🎯 on GKOS : 17% (12 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
in progress (365j)
matures : Oct 27, 26
BTIG ↗
Oct 20, 25
▲ Buy · 🎯$104
Price at call : $79.47 — upside +31%
Today : $165.5 — upside -37%
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
in progress (365j)
matures : Oct 20, 26
BTIG ↗
Oct 13, 25
▲ Buy · 🎯$104
Price at call : $83.09 — upside +25%
Today : $165.5 — upside -37%
Expected +25% · Actual +99% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
+99.2%
stock +99% · XLV +20%
matured Oct 13, 26
Citigroup ↗
Oct 7, 25
▲ Buy · 🎯$110
Price at call : $87.59 — upside +26%
Today : $165.5 — upside -34%
Expected +26% · Actual +84% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 100% (1 call matured) · 📊 on Health : 44.9% · -4.4% (107 calls)
+84.1%
stock +84% · XLV +16%
matured Oct 7, 26
Goldman Sachs ↗
Oct 1, 25
▲ Buy · 🎯$103
Price at call : $84.49 — upside +22%
Today : $165.5 — upside -38%
Expected +22% · Actual +94% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 100% (1 call matured) · 📊 on Health : 51.9% · +5.8% (104 calls)
+93.8%
stock +94% · XLV +16%
matured Oct 1, 26
▲ Buy · 🎯$120
Price at call : $84.69 — upside +42%
Today : $165.5 — upside -27%
Expected +42% · Actual +81% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 50% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
+81.2%
stock +81% · XLV +23%
matured Sep 22, 26
BTIG ↗
Sep 10, 25
▲ Buy · 🎯$118
Price at call : $87.52 — upside +35%
Today : $165.5 — upside -29%
Expected +35% · Actual +95% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
+94.7%
stock +95% · XLV +21%
matured Sep 10, 26
▲ Overweight · 🎯$115
Price at call : $86.86 — upside +32%
Today : $165.5 — upside -31%
Expected +32% · Actual +56% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 86% (7 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
+56.4%
stock +56% · XLV +5%
matured May 2, 26
▲ Buy · 🎯$135
Price at call : $87.61 — upside +54%
Today : $165.5 — upside -18%
Expected +54% · Actual +55% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 50% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
+55.1%
stock +55% · XLV +4%
matured May 1, 26
▲ Buy · 🎯$140
Price at call : $90.07 — upside +55%
Today : $165.5 — upside -15%
Expected +55% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 50% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
+32.7%
stock +33% · XLV +8%
matured Apr 11, 26
Wells Fargo ↗
Feb 21, 25
▲ Overweight · 🎯$160
Price at call : $125.88 — upside +27%
Today : $165.5 — upside -3%
Expected +27% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 17% (12 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
-4.3%
stock -4% · XLV +8%
matured Feb 21, 26
▲ Buy · 🎯$185
Price at call : $143.74 — upside +29%
Today : $165.5 — upside +12%
Expected +29% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 50% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-19.1%
stock -19% · XLV +14%
matured Dec 18, 25
Wells Fargo ↗
Dec 11, 24
▲ Overweight · 🎯$153
Price at call : $140.32 — upside +9%
Today : $165.5 — upside -8%
Expected +9% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 17% (12 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
-22.4%
stock -22% · XLV +9%
matured Dec 11, 25
BTIG ↗
Nov 26, 24
▲ Buy · 🎯$149
Price at call : $142.69 — upside +4%
Today : $165.5 — upside -10%
Expected +4% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
-25.5%
stock -26% · XLV +7%
matured Nov 26, 25
Wells Fargo ↗
Nov 5, 24
▲ Overweight · 🎯$145
Price at call : $140.64 — upside +3%
Today : $165.5 — upside -12%
Expected +3% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 17% (12 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
-41.8%
stock -42% · XLV -1%
matured Nov 5, 25
▲ Buy · 🎯$152
Price at call : $127.61 — upside +19%
Today : $165.5 — upside -8%
Expected +19% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 50% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-32.9%
stock -33% · XLV -7%
matured Oct 14, 25
BTIG ↗
Aug 28, 24
▲ Buy · 🎯$139
Price at call : $132.59 — upside +5%
Today : $165.5 — upside -16%
Expected +5% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
-27.7%
stock -28% · XLV -12%
matured Aug 28, 25
Wells Fargo ↗
Aug 1, 24
▲ Overweight · 🎯$135
Price at call : $116.03 — upside +16%
Today : $165.5 — upside -18%
Expected +16% · Actual -25% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 17% (12 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
-24.6%
stock -25% · XLV -12%
matured Aug 1, 25
▲ Buy · 🎯$145
Price at call : $117.61 — upside +23%
Today : $165.5 — upside -12%
Expected +23% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 50% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-26.7%
stock -27% · XLV -13%
matured Aug 1, 25
▲ Buy · 🎯$141
Price at call : $124.16 — upside +14%
Today : $165.5 — upside -15%
Expected +14% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 50% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-20.3%
stock -20% · XLV -12%
matured Jul 16, 25
BTIG ↗
Jul 15, 24
▲ Buy · 🎯$131
Price at call : $125.69 — upside +4%
Today : $165.5 — upside -21%
Expected +4% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
-21.6%
stock -22% · XLV -10%
matured Jul 15, 25
Wells Fargo ↗
Jun 3, 24
▲ Overweight · 🎯$120
Price at call : $111.63 — upside +7%
Today : $165.5 — upside -27%
Expected +7% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 17% (12 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
-18.5%
stock -19% · XLV -8%
matured Jun 3, 25
BTIG ↗
May 2, 24
▲ Buy · 🎯$112
Price at call : $106.51 — upside +5%
Today : $165.5 — upside -32%
Expected +5% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
-18.4%
stock -18% · XLV -2%
matured May 2, 25
Wells Fargo ↗
May 2, 24
▲ Overweight · 🎯$110
Price at call : $106.51 — upside +3%
Today : $165.5 — upside -34%
Expected +3% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 17% (12 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
-18.4%
stock -18% · XLV -2%
matured May 2, 25
▲ Buy · 🎯$125
Price at call : $105.03 — upside +19%
Today : $165.5 — upside -24%
Expected +19% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 50% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-16.6%
stock -17% · XLV -1%
matured May 2, 25
▲ Buy · 🎯$110
Price at call : $101.31 — upside +9%
Today : $165.5 — upside -34%
Expected +9% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 50% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
-7.7%
stock -8% · XLV -3%
matured Apr 8, 25
▲ Buy · 🎯$110
Price at call : $88.72 — upside +24%
Today : $165.5 — upside -34%
Expected +24% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 50% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
+21.3%
stock +21% · XLV +1%
matured Mar 22, 25
Wells Fargo ↗
Feb 22, 24
▲ Overweight · 🎯$103
Price at call : $89.57 — upside +15%
Today : $165.5 — upside -38%
Expected +15% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 17% (12 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
+38.7%
stock +39% · XLV -0%
matured Feb 21, 25
▲ Buy · 🎯$100
Price at call : $79.49 — upside +26%
Today : $165.5 — upside -40%
Expected +26% · Actual +88% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 50% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
+88.1%
stock +88% · XLV +1%
matured Dec 28, 24
▲ Buy · 🎯$100
Price at call : $79.79 — upside +25%
Today : $165.5 — upside -40%
Expected +25% · Actual +86% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 50% (12 calls matureds) · 📊 on Health : 38.1% · -0.3% (168 calls)
+85.9%
stock +86% · XLV +3%
matured Dec 21, 24
Wells Fargo ↗
Nov 8, 23
▲ Overweight · 🎯$83
Price at call : $64.18 — upside +29%
Today : $165.5 — upside -50%
Expected +29% · Actual +117% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 17% (12 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
+117.1%
stock +117% · XLV +16%
matured Nov 7, 24
BTIG ↗
Jun 5, 23
▲ Buy · 🎯$67
Price at call : $62.61 — upside +7%
Today : $165.5 — upside -60%
Expected +7% · Actual +78% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
+78.3%
stock +78% · XLV +11%
matured Jun 4, 24
▲ Overweight · 🎯$71
Price at call : $58.66 — upside +21%
Today : $165.5 — upside -57%
Expected +21% · Actual +84% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 86% (7 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
+84.1%
stock +84% · XLV +7%
matured May 7, 24
▲ Overweight · 🎯$69
Price at call : $50.57 — upside +36%
Today : $165.5 — upside -58%
Expected +36% · Actual +111% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 86% (7 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
+110.6%
stock +111% · XLV +6%
matured May 3, 24
Stephens & Co. ↗
Dec 28, 22
▲ Overweight · 🎯$68
Price at call : $41.28 — upside +65%
Today : $165.5 — upside -59%
Expected +65% · Actual +95% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 86% (7 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
+94.8%
stock +95% · XLV +1%
matured Dec 28, 23
BTIG ↗
Aug 4, 22
▲ Buy · 🎯$67
Price at call : $53.5 — upside +25%
Today : $165.5 — upside -60%
Expected +25% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
+39.1%
stock +39% · XLV +1%
matured Aug 4, 23
BTIG ↗
May 5, 22
▲ Buy · 🎯$62
Price at call : $44.91 — upside +38%
Today : $165.5 — upside -63%
Expected +38% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
+21.3%
stock +21% · XLV +3%
matured May 5, 23
BTIG ↗
Apr 18, 22
▲ Buy · 🎯$66
Price at call : $59.26 — upside +11%
Today : $165.5 — upside -60%
Expected +11% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
-18.4%
stock -18% · XLV -3%
matured Apr 18, 23
BTIG ↗
Jan 18, 22
▲ Buy · 🎯$61
Price at call : $51.76 — upside +18%
Today : $165.5 — upside -63%
Expected +18% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 45% (11 calls matureds) · 📊 on Health : 47.1% · +20.0% (68 calls)
-6.6%
stock -7% · XLV +1%
matured Jan 18, 23
▲ Overweight · 🎯$68
Price at call : $53.46 — upside +27%
Today : $165.5 — upside -59%
Expected +27% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on GKOS : 86% (7 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
-9.7%
stock -10% · XLV -4%
matured Nov 3, 22
Wells Fargo ↗
Jul 20, 21
▼ Underweight · 🎯$41
Price at call : $47.93 — upside -14%
Today : $165.5 — upside -75%
Expected -14% · Actual +5% · Reason (≤ −15%) : ✗ No
🎯 on GKOS : 17% (12 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
-4.5%
stock +5% · XLV -0%
matured Jul 20, 22
Wells Fargo ↗
Apr 8, 20
▼ Underweight · 🎯$34
Price at call : $32.61 — upside +4%
Today : $165.5 — upside -79%
Expected +4% · Actual +163% · Reason (≤ −15%) : ✗ No
🎯 on GKOS : 17% (12 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
-163.2%
stock +163% · XLV +24%
matured Apr 8, 21
Stephens & Co. ↗
Mar 23, 20
▲ Overweight · 🎯$44
Price at call : $30.82 — upside +43%
Today : $165.5 — upside -73%
Expected +43% · Actual +166% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 86% (7 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
+165.7%
stock +166% · XLV +42%
matured Mar 23, 21
Wells Fargo ↗
Feb 28, 20
▼ Underweight · 🎯$53
Price at call : $43.98 — upside +21%
Today : $165.5 — upside -68%
Expected +21% · Actual +122% · Reason (≤ −15%) : ✗ No
🎯 on GKOS : 17% (12 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
-121.5%
stock +122% · XLV +23%
matured Feb 27, 21
Stephens & Co. ↗
Feb 28, 20
▲ Overweight · 🎯$69
Price at call : $43.98 — upside +57%
Today : $165.5 — upside -58%
Expected +57% · Actual +122% · Reason (≥ +15%) : ✓ Yes
🎯 on GKOS : 86% (7 calls matureds) · 📊 on Health : 44.3% · +2.1% (88 calls)
+121.5%
stock +122% · XLV +23%
matured Feb 27, 21
Wells Fargo ↗
Dec 12, 19
▼ Underweight · 🎯$58
Price at call : $56.99 — upside +2%
Today : $165.5 — upside -65%
Expected +2% · Actual +18% · Reason (≤ −15%) : ✗ No
🎯 on GKOS : 17% (12 calls matureds) · 📊 on Health : 38.3% · +2.0% (107 calls)
-18.3%
stock +18% · XLV +11%
matured Dec 11, 20

Frequently asked questions

Should I buy Glaukos Corp. stock?

This isn't buy advice. For Glaukos Corp., the analyst consensus is "Buy", with an average price target of $195 (+18% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Glaukos Corp.). We show the numbers — you decide.

Is it too late to buy Glaukos Corp.? How high can it go?

The most bullish analyst target on Glaukos Corp. is $215 (+30% above today's price); the average is $195. That's the upside they see. Check how reliable those analysts have actually been on Glaukos Corp. on our site before trusting it.

Is Glaukos Corp. still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 16 analysts have a real record on Glaukos Corp., the best hitting 100% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.

Should you invest in Glaukos Corp.? The case for and against

The arguments for and against, one by one, from the numbers: why invest in GKOS (and why hesitate).

What has Glaukos Corp.'s past performance been?

Historical returns and a "how much if I had invested" calculator: GKOS performance & returns.

What is the best month to buy GKOS?

The 12 months ranked by the stock's past returns: best & worst month to buy GKOS.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)